COMING SOON: NEXT Houston! We are delighted to open our newest location – NEXT Houston, located in the Texas Medical Center at 7500 Fannin, Suite 500.?Dr. Peter De Maria and Dr. Jennifer Segar will be our lead clinical oncologists.
NEXT Oncology
医院和医疗保健
SAN ANTONIO，TX 2,284 位关注者
A Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research.
关于我们
NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough. Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers. This is not a job for Dr. Tolcher, it is his passion.
- 网站
-
https://nextoncology.com
NEXT Oncology 的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 201-500 人
- 总部
- SAN ANTONIO，TX
- 类型
- 合营企业
- 创立
- 2018
- 领域
- cancer research、phase 1 clinical trials和oncology
地点
NEXT Oncology 员工
-
Aracely Cavazos
VP Regulatory Affairs & Administration at NEXT Oncology
-
Gina Mangold
Executive VP & COO at NEXT Oncology San Antonio
-
Anthony Tolcher
CEO, Founder and Director of Clinical Research at NEXT, San Antonio
-
Rachel K Branch
Financial Literacy Advocate, Past CEO of Trinity House of Love, Inc.
动态
-
Colorectal cancer is among the most underfunded in cancer research, even though it’s the #1 deadliest cancer for men and #2 deadliest cancer for women. Learn more here:?https://lnkd.in/gV4N63Mb?#ColorectalCancerAwarenessMonth
-
ICYMI: The first patient in Innate Pharma's innovative Phase 1 trial was recently treated at NEXT Dallas.?Read more here.
-
WELCOME Dr. Jennifer Segar! Dr. Segar is a Phase 1 clinical investigator at NEXT Oncology - Houston, opening this March. She is board certified in medical oncology, hematology, and internal medicine. She leads multiple clinical trials at NEXT with the mindset of providing additional treatment options for patients who have progressed on standard of care or are looking to try something novel. Her ultimate goal is to discover improved treatments for future cancer patients, while prioritizing the care of her current patients. Dr. Segar earned her medical degree from Ross University School of Medicine and completed her internal medicine residency at the University of Arizona in Tucson, where she also served as Chief Resident. She then pursued a hematology and oncology fellowship at the University of Arizona Cancer Center, where she also served as Chief Fellow. Following her fellowship, Dr. Segar joined the University of Arizona faculty, focusing on breast cancer. She developed a strong passion for Phase 1 clinical trials and eventually led the Phase 1 clinical research team for solid tumors.
-
-
We are proud to work with Aprea Therapeutics to advance its promising therapeutic treatment.